Sodium butyrate in Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder characterized by abdominal pain, bloating, and altered bowel habits. Although its pathophysiology is not fully understood, factors such as gut microbiota imbalance, increased intestinal permeability, and low-grade inflam...
Saved in:
| Main Authors: | Aleksandra Kołodziej, Wiktoria Zamirska, Nadia Hornig, Aleksandra Cieplak, Zuzanna Czyżewicz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kazimierz Wielki University
2025-06-01
|
| Series: | Journal of Education, Health and Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/JEHS/article/view/60166 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sodium Butyrate in The Treatment of Irritable Bowel Syndrome KG
by: Karolina Grabowska, et al.
Published: (2025-04-01) -
The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
by: Konrad Lewandowski, et al.
Published: (2022-01-01) -
Efficiency of butyric acid and inulin in patients with irritable bowels syndrome: results of multicenter study
by: S. V. Levchenko, et al.
Published: (2021-06-01) -
Isolation and Identification of the Types of Bacteria that Cause Irritable Bowel Syndrome
by: Noor Mahmood Sultan, et al.
Published: (2025-01-01) -
Ultrasound for evaluating gastrointestinal symptoms in irritable bowel syndrome patients: A systematic review
by: Anas Elgenidy, et al.
Published: (2024-12-01)